Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ETON

Price
17.15
Stock movement up
+0.08 (0.47%)
Company name
Eton Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
459.92M
Ent value
504.18M
Price/Sales
6.54
Price/Book
19.89
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
16.98
PEG
-
EPS growth
-32.22%
1 year return (CAGR)
2.02%
3 year return (CAGR)
69.05%
5 year return (CAGR)
11.66%
10 year return (CAGR)
-
Last updated: 2026-02-24

DIVIDENDS

ETON does not pay dividends or no data was received

FINANCIALS

Per share

Loading...
Per share data
Current share count26.82M
EPS (TTM)-0.25
FCF per share (TTM)0.78

Income statement

Loading...
Income statement data
Revenue (TTM)70.32M
Gross profit (TTM)36.12M
Operating income (TTM)-2.68M
Net income (TTM)-6.68M
EPS (TTM)-0.25
EPS (1y forward)1.01

Margins

Loading...
Margins data
Gross margin (TTM)51.36%
Operating margin (TTM)-3.81%
Profit margin (TTM)-9.50%

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)21.31M
Capital expenditures (TTM)296.00K
Free cash flow (TTM)21.01M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-28.89%
Return on Assets-6.39%
Return on Invested Capital-12.49%
Cash Return on Invested Capital39.28%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open17.27
Daily high17.52
Daily low16.79
Daily Volume257K
All-time high22.48
1y analyst estimate30.00
Beta1.22
EPS (TTM)-0.25
Dividend per share0.00
Ex-div date-
Next earnings date12 Mar 2026

Downside potential

Loading...
Downside potential data
ETONS&P500
Current price drop from All-time high-23.71%-1.82%
Highest price drop-79.94%-56.47%
Date of highest drop20 Oct 20229 Mar 2009
Avg drop from high-38.78%-10.84%
Avg time to new high36 days12 days
Max time to new high942 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ETON (Eton Pharmaceuticals Inc) company logo
Marketcap
459.92M
Marketcap category
Small-cap
Description
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Employees
31
Investor relations
-
SEC filings
CEO
Sean Brynjelsen
Country
USA
City
Deer Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...